Alpha 2.0
Login Register
» Authors » Eva van der Veer

Eva van der Veer

Explore the profile of Eva van der Veer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 240
Followers 0
Related Specialties
Biology
General Medicine
Pharmacology
Top 10 Co-Authors
Charles H J M Fransen
Pavlina Frolova
Amy K Patick
Adam Pavlicek
Michael R Hodges
Janke Schinkel
Richard Molenkamp
Meike H Van der Ree
Ulrich Beuers
Karin Zeh
Published In
Antimicrob Agents Chemother
Invertebr Syst
Lancet
Zootaxa
Affiliations
Soon will be listed here.
Recent Articles
1.
A review of (Decapoda: Caridea: Palaemonidae), with clarification of the taxonomic status of , and
Frolova P, van der Veer E, Fransen C, duris Z
Invertebr Syst . 2024 May; 38. PMID: 38744492
The pantropical genus Palaemonella Dana, 1852 (Caridea: Palaemonidae) currently includes 27 species of free-living and symbiotic marine shrimps. The monophyly of Palaemonella with respect to several closely related genera, however,...
2.
A new species of scleractinian associated shrimp of the genus Palaemonella (Crustacea, Decapoda, Palaemonidae) with a redescription of Palaemonella orientalis Dana, 1852
Fransen C, van der Veer E, Frolova P
Zootaxa . 2023 Apr; 5214(4):557-580. PMID: 37044890
A new species of Palaemonella, P. rubrolineata sp. nov., is described on the basis of material collected from pocilloporid corals in Indonesia and Vanuatu. The new species is most closely...
3.
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
Van der Ree M, de Vree J, Stelma F, Willemse S, Van Der Valk M, Rietdijk S, et al.
Lancet . 2017 Jan; 389(10070):709-717. PMID: 28087069
Background: miR-122 is an important host factor for hepatitis C virus (HCV) replication. The aim of this study was to assess the safety and tolerability, pharmacokinetics, and antiviral effect of...
4.
In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122
Ottosen S, Parsley T, Yang L, Zeh K, van Doorn L, van der Veer E, et al.
Antimicrob Agents Chemother . 2014 Nov; 59(1):599-608. PMID: 25385103
Miravirsen is a β-D-oxy-locked nucleic acid-modified phosphorothioate antisense oligonucleotide targeting the liver-specific microRNA-122 (miR-122). Miravirsen demonstrated antiviral activity against hepatitis C virus (HCV) genotype 1b replicons with a mean 50%...